Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?

Despite evidence of improved diabetes outcomes with diabetes technology such as continuous glucose monitoring (CGM) systems, insulin pumps, and hybrid closed-loop (HCL) insulin delivery systems, these devices are underutilized in clinical practice for the management of insulin-requiring diabetes. This low uptake may be the result of health care providers' (HCPs') lack of confidence or time to prescribe and manage devices for people with diabetes. We administered a survey to HCPs in primary care, pediatric endocrinology, and adult endocrinology practices in the United States. Responding HCPs expressed a need for device-related insurance coverage tools and online data platforms with integration to electronic health record systems to improve diabetes technology uptake in these practice settings across the United States.
Competing Interests: L.H.M. has received research/education grants from Beta Bionics, Insulet, the Leona M. and Harry B. Helmsley Charitable Trust, the National Institutes of Health, and Tandem Diabetes Care. She has served as a consultant/speaker for Capillary Biomedical, Dexcom, and Tandem Diabetes Care and on an advisory board for Eli Lilly. As of January 2023, she is also employed by Tandom Diabetes Care. H.K.A. has received research grants from Dexcom, Eli Lilly, the Institute for the Advancement of Food and Nutrition Sciences, IM Therapeutics, Mannkind, Medtronic, REMD Biotherapeutics, and Senseonics. He has served as a consultant for Eli Lilly and on advisory boards for Ascensia and Mannkind. G.P.F. has received research grants from Abbott, Beta Bionics, Dexcom, Eli Lilly, Insulet, JDRF, Medtronic, and Tandem Diabetes Care and has served as a consultant/speaker for Abbott, Beta Bionics, Dexcom, Insulet, Eli Lilly, Medtronic, and Tandem Diabetes Care. S.M.O. has received research grants from the AAFP, the Colorado Department of Public Health & Environment, and the Leona M. and Harry B. Helmsley Charitable Trust. He has served on advisory boards for the ADA, ADCES, Cecelia Health, Dexcom, the Jaeb Center for Health Research, Medtronic, the National Committee on Quality Assurance, and Pendulum Therapeutics. S.P. has received research grants from Dexcom, Eli Lilly, JDRF, the Leona M. and Harry B. Helmsley Charitable Trust, Medtronic, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Sanofi and has served on an advisory board for Medtronic. V.N.S. has received research grants from Dexcom, Eli Lilly, Insulet, JDRF, the National Institutes of Health, Novo Nordisk, and Tandem Diabetes Care. He has served as a consultant/speaker for Dexcom and Insulet and on advisory boards for DKSH Singapore, LifeScan, and Medscape. R.P.W. has received research grant support from Dexcom and Tandem Diabetes Care and has served as a consultant/speaker for Tandem Diabetes Care. T.K.O. has received research grants from Abbott, the AAFP, the Leona M. and Harry B. Helmsley Charitable Trust, the National Institute of Nursing Research, and NIDDK. She has served on advisory boards for ADA, ADCES, Cecelia Health, Dexcom, and the Jaeb Center for Health Research. No other potential conflicts of interest relevant to this article were reported.
(© 2023 by the American Diabetes Association.)